Autogenous Vaccine Market

Autogenous Vaccine Market Study by Bacterial Strain and Virus Strain for Veterinary Research Institutes, Livestock Farming Companies, and Veterinary Clinics & Hospitals from 2024 to 2034

Analysis of Autogenous Vaccine Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Autogenous Vaccine Market Outlook (2024 to 2034)

As per Fact.MR’s new market research report, the global autogenous vaccine market is estimated to be valued at US$ 144.8 million in 2024. Worldwide demand for autogenous vaccines is forecasted to increase at 5.5% CAGR and reach a market value of US$ 246.8 million by the end of 2034.

Autogenous vaccines are specially developed to address some particular pathogens or diseases present within a certain animal group or in a particular region. There is a growing demand for customized solutions to address diseases, which are not efficiently covered through conventional vaccines. Further, increasing awareness about the importance of animal welfare and health among veterinarians, regulatory bodies, and farmers is projected to generate requirements for tailored and effective solutions to combat different diseases affecting animals.

Significant expansion of the livestock sector is forecasted to boost demand for autogenous vaccines. With increasing demand for animal-derived products, there is a parallel requirement to ensure the well-being and health of livestock, which is generating demand for customized vaccines. Increasing regulatory pressure and concerns about antibiotic resistance to minimize their use in livestock are projected to lead to rising interest in alternative strategies for disease management, which include vaccines as a safer option.

  • Demand for autogenous vaccines in China is forecasted to increase at 4.3% CAGR and reach a valuation of US$ 5 million by the end of 2034.
  • North America is projected to account for 34.8% of the global autogenous vaccine market share by 2034.
  • Livestock farming companies are forecasted to account for 45.3% share of global market revenue by 2034.

Regulatory bodies in many countries are forecasted to show support and flexibility for the approval of autogenous vaccines owing to an increasing understanding of their importance in addressing specific diseases in animals. Furthermore, outbreaks of animal diseases, particularly with economic impacts, are projected to increase the requirements for targeted and rapid responses, therefore positively contributing to the expansion of the autogenous vaccine market size.

Report Attributes Details
Autogenous Vaccine Market Size (2024E) US$ 144.8 Million
Forecasted Market Value (2034F) US$ 246.8 Million
Global Market Growth Rate (2024 to 2034) 5.5% CAGR
United States Market Share (2034F) 93.6%
Bacteria Strains Segment Market Share (2034F) 71%
Mexico Market Growth Rate (2024 to 2034) 4.6% CAGR
Key Companies Profiled Newport Laboratories, Inc.; Ceva; Elanco Animal Health; ACE Laboratory Services; AniCon Labor GmbH; Huvepharma, Inc.; Cambridge Technologies; Dyntec s. r. o.; Vaxxinova; Hygieia Biological Laboratories; Sanphar; Addison Biological Laboratory; Kennebec River Biosciences; Barramundi Asia Pte Ltd.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Which Key Factors are Positively Influencing Autogenous Vaccine Market Growth?

“Growing Demand for Autogenous Vaccines for Livestock Management”

In recent times, there has been a growing demand to enhance animal husbandry practices. In addition, growing emphasis is given to minimizing the use of antibiotics for the treatment of sick herds or animals with increasing public interest in animal health and welfare. Further, many developed countries are emphasizing minimizing the use of antibiotics to reduce animal loss.

Owing to the limited availability of some veterinary medicines, it is difficult to manage health issues for some species, especially minor ones such as the turkey. Thus, demand for accessible products, such as autogenous vaccines, is projected to rise in the coming 10 years.

“Focus on Production of Customized Autogenous Vaccines”

Encountering constant changes and evolution in reoviruses is common. Various serotypes are harmful to the health and performance of poultry. Therefore, several manufacturers are emphasizing the production of customized autogenous poultry reovirus vaccines. Farm-specific setups are included in these vaccines to ensure a close match for the constantly changing environment of the farms. Autogenous vaccinations are recognized as an efficient approach to addressing antigenic changes in the fields.

For instance :

  • In April 2020, Phibro Animal Health Company added antigen combinations to its available range of autogenous vaccines. These customized and advanced vaccines are projected to assist poultry farmers in protecting their animals against several infectious diseases.

What are Market Players Focusing on to Remain Competitive?

“Stringent Regulatory Framework for Production and Export of Vaccines”

Autogenous vaccines are specialized vaccinations, which are produced from antigens. Therefore, a licensed facility is pivotal in this regard. In addition, there are differences in the regulatory laws among countries. Every country has its license regulations and requirements for vaccine production. Therefore, an absence of set uniform regulations is projected to adversely impact autogenous vaccine market growth.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Why are Startups Invest in This Business?

“Production of Customized Vaccines Leveraging Advancements in Biotechnology”

Advancements taking place in molecular biology and biotechnology are estimated to facilitate the development of more efficient autogenous vaccines. Several techniques, including proteomics, bioinformatics, and genomics are forecasted to play a pivotal role in the development and production of these customized vaccines, which are further projected to attract startups to invest in the market.

Country-wise Insights

North America is forecasted to hold 34.8% of the global market share by 2034 owing to the rising incidences of livestock-related diseases, including otitis externa, sinusitis, pharyngitis, and dermatitis. Further, the growing use of customized vaccines to treat these diseases is projected to contribute to autogenous vaccine market trends.

Why is the United States Garnering the Attention of Players?

“Supportive Government Initiatives for Veterinary Care”

Attribute United States
Market Value (2024E) US$ 50 Million
Growth Rate (2024 to 2034) 4.9% CAGR
Projected Value (2034F) US$ 80 Million

The United States is forecasted to hold 93.6% share of the North American market by 2034. Farmers in the United States are made aware of the impact of livestock diseases along with their preventive measures through government programs and initiatives.

Public health officials, manufacturers, the USDA’s ARS (Animal Research Service), etc., work together for conducting surveillance programs for advancing scientific studies to address issues of public and veterinary health. These campaigns are projected to increase awareness about animal health, therefore contributing to the rising demand for autogenous vaccines.

Why are Suppliers of Autogenous Vaccines Interested in China?

“Increasing Use of Animal Vaccines amid Rising Incidence of Livestock-Related Diseases”

Attribute China
Market Value (2024E) US$ 4 Million
Growth Rate (2024 to 2034) 4.3% CAGR
Projected Value (2034F) US$ 5 Million

China is projected to occupy 89.4% share of the East Asia market by 2034. Increasing incidences of livestock-related diseases in the country along with the growing use of animal vaccines is forecasted to positively impact consumption of autogenous vaccines, therefore contributing to market growth.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Category-wise Insights

Fact.MR, through its newly published study, asserts that traction for bacterial strains is projected to increase further owing to their higher stability cultures in incubators and in vitro labs. In addition, the built-in adjuvant qualities of these strains are also projected to contribute to their increased demand.

Which Type of Autogenous Vaccines are Preferred for Livestock Disease Management?

“Widespread Adoption of Bacterial Vaccines Due to More Efficient Oral Administration Options”

Attribute Bacterial Strain
Segment Value (2024E) US$ 98.7 Million
Growth Rate (2024 to 2034) 5.9% CAGR
Projected Value (2034F) US$ 175.2 Million

Bacterial strains are projected to hold 71% share of the global market by 2034, as per the research analysis published by Fact.MR, a market research and competitive intelligence provider. Live bacterial vaccines offer multiple benefits, including built-in adjuvant qualities, the ability to replace real infection, and more efficient oral administration options. Thus, these benefits are projected to generate demand for bacterial strains for the development of customized autogenous vaccines.

What is the Contribution of Livestock Farming Companies to the Global Market?

“High Demand for Animal Products Driving Substantial Autogenous Vaccine Use by Livestock Companies”

Attribute Livestock Farming Companies
Segment Value (2024E) US$ 68.8 Million
Growth Rate (2024 to 2034) 5% CAGR
Projected Value (2034F) US$ 111.8 Million

Livestock farming companies are forecasted to account for 45.3% share of global market revenue by 2034, according to the analysis published by Fact.MR. The livestock sector is very active around the world. Significant transformations in the livestock sector in potentially high-growth markets are attributed to the increasing demand for various types of animal products. Growing urbanization, income, and human population are projected to increase the consumption of livestock products, thus driving market growth.

Competitive Landscape

Presence of regional and global players is making the market highly competitive. Market players are emphasizing inorganic expansion as one of the prominent growth strategies to maintain competitiveness.

Expenditures for the strengthening of the supply chain management system, offering quality products, new developments, etc., are set to help companies secure their position. In addition, participants are also working to increase their reach across regions through acquisitions, mergers, etc.

For instance :

  • Ceva Sante Animale, in September 2020, tripled its capability for autogenous vaccine production at its French facility.

Key players in the autogenous vaccine market are Newport Laboratories, Inc., Ceva, Elanco Animal Health, ACE Laboratory Services, AniCon Labor GmbH, Huvepharma, Inc., Cambridge Technologies, Dyntec s. r. o., Vaxxinova, Hygieia Biological Laboratories, Sanphar, Addison Biological Laboratory, Kennebec River Biosciences, and Barramundi Asia Pte Ltd.

Segmentation of Autogenous Vaccine Market Research

  • By Product Type :

    • Bacterial Strain
    • Virus Strain
  • By End User :

    • Veterinary Research Institutes
    • Livestock Farming Companies
    • Veterinary Clinics & Hospitals
  • By Region :

    • North America
    • Europe
    • East Asia
    • Latin America
    • Middle East & Africa
    • South Asia & Oceania

Table of Content

  • 1. Executive Summary
  • 2. Market Overview
  • 3. Key Market Trends
  • 4. Key Success Factors
  • 5. Market Background
  • 6. Global Market Volume (Units) Analysis (2018 to 2023) and Forecast (2024 to 2034)
  • 7. Global Market - Pricing Analysis
  • 8. Global Market Value Analysis (2018 to 2023) and Forecast (2024 to 2034)
  • 9. Global Market Analysis (2018 to 2023) and Forecast (2024 to 2034), by Product Type
    • 9.1. Bacterial Strain
    • 9.2. Virus Strain
  • 10. Global Market Analysis (2018 to 2023) and Forecast (2024 to 2034), by End User
    • 10.1. Veterinary Research Institutes
    • 10.2. Livestock Farming Companies
    • 10.3. Veterinary Clinics & Hospitals
  • 11. Global Market Analysis (2018 to 2023) and Forecast (2024 to 2034), by Region
    • 11.1. North America
    • 11.2. Latin America
    • 11.3. Europe
    • 11.4. East Asia
    • 11.5. South Asia
    • 11.6. Oceania
    • 11.7. Middle East and Africa (MEA)
  • 12. North America Market Analysis (2018 to 2023) and Forecast (2024 to 2034)
  • 13. Latin America Market Analysis (2018 to 2023) and Forecast (2024 to 2034)
  • 14. Europe Market Analysis (2018 to 2023) and Forecast (2024 to 2034)
  • 15. South Asia Market Analysis (2018 to 2023) and Forecast (2024 to 2034)
  • 16. East Asia Market Analysis (2018 to 2023) and Forecast (2024 to 2034)
  • 17. Oceania Market Analysis (2018 to 2023) and Forecast (2024 to 2034)
  • 18. Middle East and Africa Market Analysis (2018 to 2023) and Forecast (2024 to 2034)
  • 19. Key and Emerging Countries Market Analysis (2018 to 2023) and Forecast (2024 to 2034)
  • 20. Market Structure Analysis
  • 21. Competition Analysis
    • 21.1. Newport Laboratories, Inc.
    • 21.2. Ceva
    • 21.3. Elanco Animal Health
    • 21.4. ACE Laboratory Services
    • 21.5. AniCon Labor GmbH
    • 21.6. Huvepharma, Inc.
    • 21.7. Cambridge Technologies
    • 21.8. Dyntec s. r. o.
    • 21.9. Vaxxinova
    • 21.10. Hygieia Biological Laboratories
    • 21.11. Sanphar
    • 21.12. Addison Biological Laboratory
    • 21.13. Kennebec River Biosciences
    • 21.14. Barramundi Asia Pte Ltd.
  • 22. Assumptions and Acronyms Used
  • 23. Research Methodology

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2018 to 2034, By Product Type

Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type

Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User

Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Region

Table 05: North America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country

Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type

Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User

Table 08: Latin America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country

Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type

Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User

Table 11: Europe Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country

Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type

Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User

Table 14: South Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country

Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type

Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User

Table 17: East Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country

Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type

Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User

Table 20: Oceania Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country

Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type

Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User

Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country

Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type

Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By End User

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Market Volume (in 000' Units) Analysis, 2018 to 2023

Figure 02: Global Market Volume Forecast (in 000' Units), 2024 to 2034

Figure 03: Pricing Analysis (US$) Per Product Type, By Region, 2023

Figure 04: Pricing Analysis (US$) Per Product Type, By Region, 2023

Figure 05: Global Market Value Analysis (US$ Mn), 2018 to 2023

Figure 06: Global Market Value Forecast (US$ Mn), 2024 to 2034

Figure 07: Global Market Absolute $ Opportunity, 2024 to 2034

Figure 08: Global Market Share Analysis (%), By Product Type, 2024 to 2034

Figure 09: Global Market Y-o-Y Analysis (%), By Product Type, 2024 to 2034

Figure 10: Global Market Attractiveness Analysis by Product Type, 2024 to 2034

Figure 11: Global Market Share Analysis (%), By End User, 2024 to 2034

Figure 12: Global Market Y-o-Y Analysis (%), By End User, 2024 to 2034

Figure 13: Global Market Attractiveness Analysis by End User, 2024 to 2034

Figure 14: Global Market Share Analysis (%), By Region, 2024 to 2034

Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2024 to 2034

Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034

Figure 17: North America Market Value Share, By Product Type, 2024 (E)

Figure 18: North America Market Value Share, By End User, 2024 (E)

Figure 19: North America Market Value Share, By Country, 2024 (E)

Figure 20: North America Market Value Analysis (US$ Mn), 2018 to 2023

Figure 21: North America Market Value Forecast (US$ Mn), 2024 to 2034

Figure 22: North America Market Attractiveness Analysis by Product Type, 2024 to 2034

Figure 23: North America Market Attractiveness Analysis by End User, 2024 to 2034

Figure 24: North America Market Attractiveness Analysis by Country, 2024 to 2034

Figure 25: Latin America Market Value Share, By Product Type, 2024 (E)

Figure 26: Latin America Market Value Share, By End User, 2024 (E)

Figure 27: Latin America Market Value Share, By Country, 2024 (E)

Figure 28: Latin America Market Value Analysis (US$ Mn), 2018 to 2023

Figure 29: Latin America Market Value Forecast (US$ Mn), 2024 to 2034

Figure 30: Latin America Market Attractiveness Analysis by Product Type, 2024 to 2034

Figure 31: Latin America Market Attractiveness Analysis by End User, 2024 to 2034

Figure 32: Latin America Market Attractiveness Analysis by Country, 2024 to 2034

Figure 33: Europe Market Value Share, By Product Type, 2024 (E)

Figure 34: Europe Market Value Share, By End User, 2024 (E)

Figure 35: Europe Market Value Share, By Country, 2024 (E)

Figure 36: Europe Market Value Analysis (US$ Mn), 2018 to 2023

Figure 37: Europe Market Value Forecast (US$ Mn), 2024 to 2034

Figure 38: Europe Market Attractiveness Analysis by Product Type, 2024 to 2034

Figure 39: Europe Market Attractiveness Analysis by End User, 2024 to 2034

Figure 40: Europe Market Attractiveness Analysis by Country, 2024 to 2034

Figure 41: South Asia Market Value Share, By Product Type, 2024 (E)

Figure 42: South Asia Market Value Share, By End User, 2024 (E)

Figure 43: South Asia Market Value Share, By Country, 2024 (E)

Figure 44: South Asia Market Value Analysis (US$ Mn), 2018 to 2023

Figure 45: South Asia Market Value Forecast (US$ Mn), 2024 to 2034

Figure 46: South Asia Market Attractiveness Analysis by Product Type, 2024 to 2034

Figure 47: South Asia Market Attractiveness Analysis by End User, 2024 to 2034

Figure 48: South Asia Market Attractiveness Analysis by Country, 2024 to 2034

Figure 49: East Asia Market Value Share, By Product Type, 2024 (E)

Figure 50: East Asia Market Value Share, By End User, 2024 (E)

Figure 51: East Asia Market Value Share, By Country, 2024 (E)

Figure 52: East Asia Market Value Analysis (US$ Mn), 2018 to 2023

Figure 53: East Asia Market Value Forecast (US$ Mn), 2024 to 2034

Figure 54: East Asia Market Attractiveness Analysis by Product Type, 2024 to 2034

Figure 55: East Asia Market Attractiveness Analysis by End User, 2024 to 2034

Figure 56: East Asia Market Attractiveness Analysis by Country, 2024 to 2034

Figure 57: Oceania Market Value Share, By Product Type, 2024 (E)

Figure 58: Oceania Market Value Share, By End User, 2024 (E)

Figure 59: Oceania Market Value Share, By Country, 2024 (E)

Figure 60: Oceania Market Value Analysis (US$ Mn), 2018 to 2023

Figure 61: Oceania Market Value Forecast (US$ Mn), 2024 to 2034

Figure 62: Oceania Market Attractiveness Analysis by Product Type, 2024 to 2034

Figure 63: Oceania Market Attractiveness Analysis by End User, 2024 to 2034

Figure 64: Oceania Market Attractiveness Analysis by Country, 2024 to 2034

Figure 65: Middle East and Africa Market Value Share, By Product Type, 2024 (E)

Figure 66: Middle East and Africa Market Value Share, By End User, 2024 (E)

Figure 67: Middle East and Africa Market Value Share, By Country, 2024 (E)

Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2018 to 2023

Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2024 to 2034

Figure 70: Middle East and Africa Market Attractiveness Analysis by Product Type, 2024 to 2034

Figure 71: Middle East and Africa Market Attractiveness Analysis by End User, 2024 to 2034

Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2024 to 2034

Figure 73: UNITED STATES Market Value Analysis (US$ Mn), 2024 & 2034

Figure 74: UNITED STATES Market Value Share, By Product Type, 2024 (E)

Figure 75: UNITED STATES Market Value Share, By End User, 2024 (E)

Figure 76: Canada Market Value Analysis (US$ Mn), 2024 & 2034

Figure 77: Canada Market Value Share, By Product Type, 2024 (E)

Figure 78: Canada Market Value Share, By End User, 2024 (E)

Figure 79: Mexico Market Value Analysis (US$ Mn), 2024 & 2034

Figure 80: Mexico Market Value Share, By Product Type, 2024 (E)

Figure 81: Mexico Market Value Share, By End User, 2024 (E)

Figure 82: Brazil Market Value Analysis (US$ Mn), 2024 & 2034

Figure 83: Brazil Market Value Share, By Product Type, 2024 (E)

Figure 84: Brazil Market Value Share, By End User, 2024 (E)

Figure 85: UNITED KINGDOM Market Value Analysis (US$ Mn), 2024 & 2034

Figure 86: UNITED KINGDOM Market Value Share, By Product Type, 2024 (E)

Figure 87: UNITED KINGDOM Market Value Share, By End User, 2024 (E)

Figure 88: Germany Market Value Analysis (US$ Mn), 2024 & 2034

Figure 89: Germany Market Value Share, By Product Type, 2024 (E)

Figure 90: Germany Market Value Share, By End User, 2024 (E)

Figure 91: France Market Value Analysis (US$ Mn), 2024 & 2034

Figure 92: France Market Value Share, By Product Type, 2024 (E)

Figure 93: France Market Value Share, By End User, 2024 (E)

Figure 94: Italy Market Value Analysis (US$ Mn), 2024 & 2034

Figure 95: Italy Market Value Share, By Product Type, 2024 (E)

Figure 96: Italy Market Value Share, By End User, 2024 (E)

Figure 97: Spain Market Value Analysis (US$ Mn), 2024 & 2034

Figure 98: Spain Market Value Share, By Product Type, 2024 (E)

Figure 99: Spain Market Value Share, By End User, 2024 (E)

Figure 100: Russia Market Value Analysis (US$ Mn), 2024 & 2034

Figure 101: Russia Market Value Share, By Product Type, 2024 (E)

Figure 102: Russia Market Value Share, By End User, 2024 (E)

Figure 103: China Market Value Analysis (US$ Mn), 2024 & 2034

Figure 104: China Market Value Share, By Product Type, 2024 (E)

Figure 105: China Market Value Share, By End User, 2024 (E)

Figure 106: Japan Market Value Analysis (US$ Mn), 2024 & 2034

Figure 107: Japan Market Value Share, By Product Type, 2024 (E)

Figure 108: Japan Market Value Share, By End User, 2024 (E)

Figure 109: South Korea Market Value Analysis (US$ Mn), 2024 & 2034

Figure 110: South Korea Market Value Share, By Product Type, 2024 (E)

Figure 111: South Korea Market Value Share, By End User, 2024 (E)

Figure 112: India Market Value Analysis (US$ Mn), 2024 & 2034

Figure 113: India Market Value Share, By Product Type, 2024 (E)

Figure 114: India Market Value Share, By End User, 2024 (E)

Figure 115: ASEAN Market Value Analysis (US$ Mn), 2024 & 2034

Figure 116: ASEAN Market Value Share, By Product Type, 2024 (E)

Figure 117: ASEAN Market Value Share, By End User, 2024 (E)

Figure 118: Australia Market Value Analysis (US$ Mn), 2024 & 2034

Figure 119: Australia Market Value Share, By Product Type, 2024 (E)

Figure 120: Australia Market Value Share, By End User, 2024 (E)

Figure 121: New Zealand Market Value Analysis (US$ Mn), 2024 & 2034

Figure 122: New Zealand Market Value Share, By Product Type, 2024 (E)

Figure 123: New Zealand Market Value Share, By End User, 2024 (E)

Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2024 & 2034

Figure 125: GCC Countries Market Value Share, By Product Type, 2024 (E)

Figure 126: GCC Countries Market Value Share, By End User, 2024 (E)

Figure 127: Turkey Market Value Analysis (US$ Mn), 2024 & 2034

Figure 128: Turkey Market Value Share, By Product Type, 2024 (E)

Figure 129: Turkey Market Value Share, By End User, 2024 (E)

Figure 130: South Africa Market Value Analysis (US$ Mn), 2024 & 2034

Figure 131: South Africa Market Value Share, By Product Type, 2024 (E)

Figure 132: South Africa Market Value Share, By End User, 2024 (E)

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

What is the valuation of the autogenous vaccine market in 2024?

The global autogenous vaccine market is estimated at US$ 144.8 million in 2024.

What is the sales projection for autogenous vaccines for 2034?

Sales of autogenous vaccines are projected to reach US$ 246.8 million by the end of 2034.

At what rate is the demand for autogenous vaccines projected to grow?

Demand for autologous vaccines is forecasted to increase at 5.5% CAGR from 2024 to 2034.

How much share of the global market is North America projected to account for?

North America is projected to hold 34.8% share of global market revenue by 2034.

At what rate are the sales of autogenous vaccines forecasted to rise in Mexico?

Sales of autogenous vaccines in Mexico are forecasted to increase at a CAGR of 4.6% from 2024 to 2034.

What is an autogenous vaccine for humans?

Autogenous vaccines are used to treat chronic infections, including respiratory tract infections, skin infections, urinary tract infections, and colon infections.

- Also of Interest -

Respiratory Virus Vaccines Market

Respiratory Virus Vaccines Market Analysis by Inactivated/Killed, Live-attenuated, and Recombinant for Influenza, Measles, Mumps, & Rubella, and Coronavirus Disease (COVID-19) from 2023 to 2033

Flu Vaccine Market

Flu Vaccine Market Study by Trivalent Flu Vaccines and Quadrivalent Flu Vaccines in Intramuscular Injections, Nasal Sprays, and Intradermal Shots from 2024 to 2034

Vaccine Adjuvants Market

Vaccine Adjuvants Market Analysis by Adjuvant Emulsions, Pathogen Components, Saponin-based Adjuvants, Particulate Adjuvants, and Other Products from 2023 to 2033

Vaccine Management Solution Market

Vaccine Management Solution Market Study by Inventory, Program, Clinical V., and Data Management; Public Engagement; Organizational Support; Managed & Professional Services from 2024 to 2034

Autogenous Vaccine Market

Schedule a Call